Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives

Scott, Anthony, Tinelli, Michela ORCID: 0000-0002-8816-4389 and Bond, Christine (2007) Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives. PharmacoEconomics, 25 (5). pp. 397-411. ISSN 1170-7690

Full text not available from this repository.

Abstract

Coronary heart disease (CHD) is the most common cause of death in the UK. CHD cost the UK National Health Service (NHS) £3.5 billion in 2003. The economic impact of community pharmacists providing a medicines management service for patients with CHD has not been rigorously evaluated; the full economic costs of such interventions are rarely presented in the literature. This paper examines the incremental costs of a 1-year community pharmacistled medicines management service for patients with CHD in the UK, from a healthcare system and patient perspective.

Item Type:	Article
Official URL:	http://www.ingentaconnect.com/content/adis/pec
Additional Information:	© 2007 Adis Data Information BV.
Divisions:	Social Policy LSE Health
Subjects:	H Social Sciences > HD Industries. Land use. Labor > HD28 Management. Industrial Management R Medicine > RA Public aspects of medicine
Date Deposited:	11 Dec 2009 15:03
Last Modified:	31 Jan 2025 17:24
URI:	http://eprints.lse.ac.uk/id/eprint/26172

Actions (login required)

View Item